Isabel joined C4 Therapeutics in March 2016 as the Senior Vice President of Strategic Alliances and Program Management. She oversees C4 Therapeutics’ strategic partnerships as well as program management for the C4T portfolio. Previously, Isabel served as Vice President of Translational Research at AVEO Oncology where she was responsible for target and biomarker discovery, preclinical research as well as leadership of strategic partnerships. Over her career Isabel contributed to the development of numerous small molecule and antibody programs playing roles of increasing responsibility at Mitotix, GPC Biotech, AVEO, Enumeral Biomedical Holdings, and with R&D partners that included Altana, Merck, OSI, and Astellas. She received her post-doctoral training at Howard Hughes Medical Institute at Johns Hopkins Medical School, holds a Ph.D. in Biology from MIT, and a Bachelor of Arts in Biochemistry from Brandeis University.